1099. A Regulatory Perspective: What Can and Cannot be Done?
Session: Interactive Session: Susceptibility Breakpoints: Controversies, Challenges, and Changes
Friday, October 4, 2013: 2:00 PM
Room: The Moscone Center: Esplanade Ballroom 301-310
Frederic Marsik, PhD, ABMM, Clinical Microbiology Consultant, New Freedom, PA

Fred Marsik received his BA from Lebanon Valley College and his MS and Ph.D. in microbiology from the University of Missouri. His post-doctoral training was in clinical microbiology and infectious diseases at Hartford Hospital, Hartford, CT. He is a clinical microbiology consultant. He recently retired from the FDA where he worked in the area of antimicrobial products serving as a clinical microbiology team leader. Previous to working for the FDA he was the director of clinical microbiology laboratories at university and community medical centers including a pediatric hospital. His work experience also includes work in the area of tobacco carcinogenicity, working for a major pharmaceutical company and a laboratory device company. He has authored journal articles and textbook chapters. His primary interests are in antimicrobials, infectious disease genomics, and rapid diagnosis of infectious diseases.

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.